Obesity and the endocrine control of food intake Flashcards

1
Q

How is the arcuate nucleus involved in controlling food intake?

A

Above median eminence

Circumventricular region/organ

Incomplete blood brain barrier, allows access to peripheral hormones

Integrates peripheral and central feeding signals

Two neuronal populations: stimulatory (NPY/Agrp neuron) and inhibitory (POMC neuron)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are the 2 neuronal populations of the arcuate nucleus?

A

NPY/Agrp neurons increase appetite

POMC neurons decrease appetite

Both sets of neurons extend to other hypothalamic and extra-hypothalamic regions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

How do human CNS mutations affect appetite?

A

No NPY or Agrp mutations associated with appetite discovered in humans.

POMC deficiency and MC4-R mutations cause morbid obesity.

Mutations not responsible for the prevalence of obesity- but useful to explain signalling.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is leptin?

A

Codes for 167 amino acid hormone.

Low when low body fat.

High when high body fat.

Central or peripheral administration decreases food intake and increases thermogenesis.

Activates POMC and inhibits NPY/Agrp neurons.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What effects does the absence of leptin have?

A

Hyperphagia

Lowered energy expenditure

Sterility

Anti-starvation hormone rather than anti-obesity hormone

Presence of leptin tells the brain that one has sufficient fat reserves for normal functioning- but high leptin has little effect

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is the role of insulin in food intake?

A

Insulin circulates at levels proportional to body fat.

Receptors in the hypothalamus.

Central administration reduces food intake.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

How may insulin coordinate glucose and energy homeostasis?

A

Insulin regulates blood glucose and body adiposity.

Insulin lowers blood glucose concentration by suppressing its production by the liver and promoting its uptake into ‘insulin-sensitive’ tissues such as muscle and fat.

Insulin also crosses the blood brain barrier to enter the CNS, where it reduces food intake and consequently reduces absorption of glucose and other nutrients into the body.

Glucose-induced insulin secretion from the pancreas increases in proportion to body adiposity, owing to the capability of expanding fat stores to induce resistance to insulin’s glucose-lowering effects.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

How does the hypothalamus regulate food intake and body weight?

A

Food intake balanced with energy expenditure.

Hypothalamus detects leptin, gherkin, PYY and other gut hormones, and has neural input from the periphery and other brain regions.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is ghrelin?

A

28aa gastric peptide hormone released from the stomach.

Has a fatty acid group attached- activates the hormone.

Regulates (drives) hunger.

Stimulates NPY/Agrp neurons.

Inhibits POMC neurons.

Increases appetite.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What cell types secretes PYY and GLP-1?

A

L cells- enteroendocrine cell type in the intestines.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What does PYY3-36 do?

A

Directly modulates neurons in the arcuate nucleus.

Inhibits NPY release.

Stimulates POMC neurons.

Decreases appetite.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is glucagon-like peptide-1, and what does it do?

A

Gut hormone coded for by the preproglucagon gene and released post-prandially.

Well-characterised incretin role in stimulating glucose-stimulated insulin release and also reduces food intake.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is saxenda?

A

Long-acting glucagon-like peptide-1 receptor agonist (liraglutide).

Synthetic, modified so can bind to circulating proteins- longer half-life.

Double the dose used for T2DM to treat obesity.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What comorbidities is obesity associated with?

A

Depression.

Sleep apnoea.

Stroke.

Myocardial infarction.

Hypertension.

Diabetes.

Bowel cancer.

Osteoarthritis.

Peripheral vascular disease.

Gout.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Discuss the thrifty gene hypothesis (James Neel, 1962).

A

Specific genes selected for to increase metabolic efficiency and fat storage.

In the context of plentiful food and little exercise, these genes predispose their carriers to obesity and diabetes.

Evolutionarily sensible to put on weight.

Thin humans didn’t survive famines, so didn’t pass their genes on to modern humans.

Populations historically prone to starvation become most obese when exposed to Western diet and sedentary lifestyle, e.g. Pima Indians, Pacific Islanders.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Discuss the adaptive drift (drifty gene) hypothesis.

A

Normal distribution of body weight- the fat are eaten, the thin starve.

10-20k years ago, humans learned to defend against predators.

Thus obesity not selected against.

Putting on body fat then a neutral change (genetic drift) though unlikely to put on much weight…

In current context, the inheritors of these genes become obese.

Animals and humans with susceptibility genes that render them prone to a multifactorial disease will not manifest the disease phenotype, such as obesity, in a healthy environment.

It is only in the presence of a toxic environment that genetic susceptibility will be expressed as the disease phenotype.

In a toxic environment, the disease phenotype will emerge in the genetically prone animals or humans, but not in the genetically resistant population.

An increase in the frequency or prevalence of a disease phenotype in a toxic environment does not exclude a strong genetic influence on the emergence of the phenotype.